Close X
Wednesday, November 27, 2024
ADVT 
Health

'Ebola vaccine showing promising results'

Darpan News Desk IANS, 02 Dec, 2014 12:49 PM
    Two Ebola vaccines undergoing clinical trials have shown promising results and would be deployed in January 2015 to West African countries affected by the epidemic, a scientist from Oxford University said Monday.
     
    Speaking at a conference of African Immunologists in Nairobi, Adrian Hill, director of Oxford University's Jenner Institute, said the two vaccines will re-energise the fight against Ebola, Xinhua reported.
     
    "The two vaccines have demonstrated remarkable efficacy and have no side effects to Ebola patients. We anticipate their deployment will commence in January," Hill told African medical researchers.
     
    The World Health Organisation (WHO) Nov 29 revealed that 6,928 people have died of Ebola in Liberia, Guinea and Sierra Leone.
     
    At the same time, 16,000 people are infected with the Ebola virus and could succumb to death in the absence of proper treatment and care.
     
    Pharmaceutical giants, rich governments, foundations and multilateral agencies have contributed funds to support development of an Ebola vaccine.
     
    Hill said that clinical trials on Ebola vaccine have accelerated thanks to adequate funding and political attention.
     
    "Development of an Ebola vaccine is accelerating faster than anticipated. The vaccine is being tested in Mali where 80 people have received the jab," Hill said, adding that over 200 people have been vaccinated against Ebola globally.
     
    The clinical trials on Ebola vaccine commenced in September and the WHO will approve it once it passes efficacy and safety test.
     
    Hill revealed that pharmaceutical giants, British and American governments have collaborated to develop the Ebola vaccine.
     
    Clinical trials on Ebola vaccine have involved primates since the disease was discovered in 1976 in the Democratic Republic of Congo.
     
    "There was a breakthrough in the clinical trials targeting monkeys and the next phase will focus on the vaccines` efficacy on humans," Hill told scientists.
     
    He emphasised the vaccine will be a game changer in the war against Ebola in West and Central Africa.
     
    "The vaccine will be availed to high risk groups like health workers and people involved in burials," Hill said. 

    MORE Health ARTICLES

    With Early Signs Flu Season Looms, It's Time To Roll Up Your Sleeve

    With Early Signs Flu Season Looms, It's Time To Roll Up Your Sleeve
    TORONTO - Summer is starting to seem like a distant memory. And the remains of your Thanksgiving turkey may not yet be boiling for soup stock.

    With Early Signs Flu Season Looms, It's Time To Roll Up Your Sleeve

    Ebola: When It's Contagious, How It Spreads And Other Things You Need To Know To Stay Safe

    Ebola: When It's Contagious, How It Spreads And Other Things You Need To Know To Stay Safe
    Only when someone is showing symptoms, which can start with vague symptoms including a fever, flu-like body aches and abdominal pain, and then vomiting and diarrhea.

    Ebola: When It's Contagious, How It Spreads And Other Things You Need To Know To Stay Safe

    Brain may produce nerve cells even after stroke

    Brain may produce nerve cells even after stroke
    Scientists have discovered a previously unknown mechanism through which the brain produces new nerve cells even after a stroke....

    Brain may produce nerve cells even after stroke

    How the Ebola virus got its name

    How the Ebola virus got its name
    The deadly Ebola virus that has killed over 3,300 people in West Africa since its current outbreak was confirmed in March, was christened in 1976 after a river....

    How the Ebola virus got its name

    Faecal capsules may treat gut infection

    Faecal capsules may treat gut infection
    C. difficile bacteria live harmlessly in many people's guts alongside hundreds of other species - all competing for space and food. But some antibiotics can kill C...

    Faecal capsules may treat gut infection

    High cholesterol ups risk of prostate cancer recurrence

    High cholesterol ups risk of prostate cancer recurrence
    Higher levels of cholesterol and triglycerides, two types of fat, in the blood of men who underwent surgery for prostate cancer, may increase risk of disease recurrence, says a study....

    High cholesterol ups risk of prostate cancer recurrence